Status:

COMPLETED

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Lead Sponsor:

Eli Lilly and Company

Conditions:

Overweight

Obesity

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to learn more about how tirzepatide affects stomach emptying in overweight/very overweight participants. Participants include those without diabetes and those with type 2 ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Have a body mass index (BMI) between 27 to 45 kilograms per meter squared (kg/m²), inclusive at screening
  • For nondiabetic subjects: as determined by medical history, physical examination, and safety assessments at screening
  • For participants with a confirmed type 2 diabetes diagnosis: The condition must be managed either by diet and exercise alone or on a stable dose of metformin for the past 3 months
  • Willing and agreeable to commit to the duration of the study and undergo study procedures as instructed by the clinic staff
  • Key Exclusion Criteria
  • Have undergone gastric bypass or bariatric surgery
  • Have received prescription drugs or over the counter drugs that promote weight loss in the past 6 months prior to screening
  • For participants with a confirmed type 2 diabetes diagnosis: Have experienced more than 1 episode of severe low blood sugar that require emergency treatment, hospitalization or third parties to administer rescue treatment, in the past 6 months
  • Have any lifetime history of a suicide attempt
  • Have other medical conditions or medical history that make participation in the study unsafe or which may interfere in the interpretation of the results of the study
  • Unwilling to comply with smoking and alcohol restrictions during the study

Exclusion

    Key Trial Info

    Start Date :

    September 15 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 7 2021

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT04407234

    Start Date

    September 15 2020

    End Date

    January 7 2021

    Last Update

    January 8 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Clinical Pharmacology of Miami

    Hialeah, Florida, United States, 33014